Patents Assigned to Recro Technology LLC
  • Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride
    Patent number: 9308177
    Abstract: The invention relates to a controlled release composition comprising a combination of isosorbide dinitrate and hydralazine, such as hydralazine hydrochloride, that in operation delivers the drug in a pulsed or multi-modal manner for the treatment of angina, ischaemic heart disease, arterial hypertension and related disease conditions. Preferably, the isosorbide dinitrate and hydralazine hydrochloride can be released from the dosage form in an erodable, diffusion and/or osmotic-controlled release profile.
    Type: Grant
    Filed: March 4, 2015
    Date of Patent: April 12, 2016
    Assignee: Recro Technology LLC
    Inventors: Gurvinder Singh Rekhi, Richard Sidwell, Sharon Hamm